Information  X 
Enter a valid email address

Impact Healthcare (IHR)

  Print      Mail a friend

Tuesday 31 December, 2019

Impact Healthcare

Director Declaration

RNS Number : 3867Y
Impact Healthcare REIT PLC
31 December 2019
 

 

31 December 2019

Impact Healthcare REIT plc

("Impact" or the "Company")

 

DIRECTOR DECLARATION

 

In accordance with Listing Rule 9.6.14R(2), Impact announces that it has been notified that Rupert Barclay, Non-Executive Director of the Company, has resigned as a Non-Executive Director of Sanditon Investment Trust PLC with effect from 5 December 2019.

 

FOR FURTHER INFORMATION PLEASE CONTACT:

Impact Health Partners LLP

Mahesh Patel

Andrew Cowley

via Maitland/AMO



Winterflood Securities Limited

Darren Willis

Neil Langford

Tel: 020 3100 0000



RBC Capital Markets

Rupert Walford

Matthew Coakes

Tel: 020 7653 4000



Maitland/AMO (Communications Adviser)

James Benjamin

Tel: 020 7379 5151

Email: [email protected]

 

The Company's LEI is: 213800AX3FHPMJL4IJ53. Its home member state is the United Kingdom.

 

A copy of this announcement will be available on the Company's website at https://www.impactreit.uk.

 

NOTES:

Impact Healthcare REIT plc is a real estate investment trust ("REIT") which aims to provide shareholders with an attractive return, principally in the form of quarterly income distributions and with the potential for capital and income growth, through exposure to a diversified portfolio of UK healthcare real estate opportunities, in particular care homes for the elderly. The Group's investment policy is to acquire, renovate, extend and redevelop high quality healthcare real estate assets in the UK and lease those assets primarily to healthcare operators providing residential healthcare services under full repairing and insuring leases.

 

The Group's Ordinary Shares were admitted to trading on the main market of the London Stock Exchange, premium segment, on 8 February 2019. The Company is a constituent of the FTSE EPRA/NAREIT index.


This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.
 
END
 
 
RDNZMMFZLMFGLZG

a d v e r t i s e m e n t